C‐reactive protein levels and risk of dementia—Observational and genetic studies of 111,242 individuals from the general population

ApoE attenuates unresolvable inflammation by complex formation with activated C1q

(2019) Changjun Yin et al.   NATURE MEDICINE

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

(2019) Brian W. Kunkle et al.   NATURE GENETICS

Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort

(2019) Katrine L Rasmussen et al.   EUROPEAN HEART JOURNAL

Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals

(2018) Katrine L. Rasmussen et al.   Alzheimers & Dementia

Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysis

(2018) Sirwan K.L. Darweesh et al.   Alzheimers & Dementia

Chronically raised C-reactive protein is inversely associated with cortical β-amyloid in older adults with subjective memory complaints

(2018) Claudie Hooper et al.   EXPERIMENTAL GERONTOLOGY

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies

(2018) Juan R. Perea et al.   Frontiers in Cellular Neuroscience

Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease

(2018) Frederic Brosseron et al.   Alzheimers Research & Therapy

The association of high sensitivity C-reactive protein and incident Alzheimer disease in patients 60 years and older: The HUNT study, Norway

(2018) Jessica Mira Gabin et al.   Immunity & Ageing

C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance

(2018) Rachel V. Jimenez et al.   Frontiers in Immunology

Decreased plasma C-reactive protein levels in APOE ε 4 allele carriers

(2018) Henna Martiskainen et al.   Annals of Clinical and Translational Neurology

An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer's disease—A cohort study of 95,442 individuals

(2018) Katrine Laura Rasmussen et al.   Alzheimers & Dementia

Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders

(2018) Symen Ligthart et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Pentraxins in Complement Activation and Regulation

(2018) Ying Jie Ma et al.   Frontiers in Immunology

Modifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis

(2017) Susanna C Larsson et al.   BMJ-British Medical Journal

Modifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis

(2017) Susanna C Larsson et al.   BMJ-British Medical Journal

Incidence of Dementia over Three Decades in the Framingham Heart Study

(2016) Claudia L. Satizabal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recent global trends in the prevalence and incidence of dementia, and survival with dementia

(2016) Martin Prince et al.   Alzheimers Research & Therapy

A Meta-Analysis of C-Reactive Protein in Patients With Alzheimer’s Disease

(2015) Changguo Gong et al.   American Journal of Alzheimers Disease and Other Dementias

Plasma levels of apolipoprotein E and risk of dementia in the general population

(2015) Katrine L. Rasmussen et al.   ANNALS OF NEUROLOGY

Fc  Receptors and Ligands and Cardiovascular Disease

(2015) K. Tanigaki et al.   CIRCULATION RESEARCH

HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study

(2015) Christiane L. Haase et al.   DIABETES

Cerebrospinal fluid and plasma C-reactive protein and aggression in personality-disordered subjects: a pilot study

(2014) Emil F. Coccaro et al.   JOURNAL OF NEURAL TRANSMISSION

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

(2014) Anders Berg Jørgensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study

(2013) Philippa J Talmud et al.   LANCET

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

(2013) Jean-Charles Lambert et al.   NATURE GENETICS

C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization

(2010) N J Timpson et al.   INTERNATIONAL JOURNAL OF OBESITY

C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study

(2010) Kristine H. Allin et al.   JNCI-Journal of the National Cancer Institute

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

(2009) Jean-Charles Lambert et al.   NATURE GENETICS

Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation

(2008)   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Association of Loss-of-Function Mutations in the ABCA1 Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease

(2008) Ruth Frikke-Schmidt   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Inflammatory markers in AD and MCI patients with different biomarker profiles

(2008) Alie Schuitemaker et al.   NEUROBIOLOGY OF AGING

Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease

(2008) Jeppe Zacho et al.   NEW ENGLAND JOURNAL OF MEDICINE

C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype

(2007) Mary N. Haan et al.   NEUROBIOLOGY OF AGING

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

(2007) Debbie A. Lawlor et al.   STATISTICS IN MEDICINE